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Therapy of bacterial urinary tract infections (UTIs) and catheter associated urinary tract infections (CAUTIs) is
still a great challenge because of the resistance of bacteria to nowadays used antibiotics and encrustation of
catheters. Bacterial cellulose (BC) as a biocompatible material with a high porosity allows incorporation of
different materials in its three dimensional network structure. In this work a low molecular weight chitosan
(Chi) polymer is incorporated in BC with different concentrations. Different characterization techniques are
used to investigate structural and optical properties of these composites. Radical scavenging activity test
shows moderate antioxidant activity of these biocompatible composites whereas in vitro release test
shows that 13.3% of chitosan is released after 72 h. Antibacterial testing of BC–Chi composites
conducted on Gram-positive and Gram-negative bacteria causing UTIs and CAUTIs (Escherichia coli,
Pseudomonas aeruginosa, Klebsiella pneumoniae) and encrustation (Proteus mirabilis) show bactericidal
effect. The morphology analysis of bacteria after the application of BC–Chi shows that they are flattened
with a rough surface, with a tendency to agglomerate and with decreased length and width. All obtained
results show that BC–Chi composites might be considered as potential biomedical agents in treatment
of UTIs and CAUTIs and as a urinary catheter coating in encrustation prevention.Introduction
Urinary tract infections (UTIs) are the most common infections
in humans that can be caused by bacteria, fungi and viruses.1
Rarely they involve the upper urinary tract and may be life
threatening if microbes spread from the kidneys to blood.
Mostly UTIs affect the lower tract (urethra and bladder) and
cause pain and burning with increased frequency of urination.
80% of bacteria UTIs are caused by Escherichia coli (E. coli), the
rest 20% are Proteus mirabilis (P. mirabilis), Klebsiella pneumo-
niae (K. pneumoniae), Pseudomonas aeruginosa (P. aeruginosa),nal Institute of the Republic of Serbia,
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; Tel: +381 113408582
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e, Nemanjina 6, 11080 Belgrade-Zemun,
the Royal Society of ChemistryStaphylococcus aureus (S. aureus) and Enterococcus faecalis (E. faecalis).
Catheter associated urinary tract infections (CAUTIs) might be
complicated with encrustation when bacteria produce ureases and
a form crystal biolm.2 The most potent producer of ureases is P.
mirabilis. The therapy for bacteria UTIs and CAUTIs involves the use
of antibiotics. Since one of the main problems of antibiotics usage is
the development of bacteria resistance to them, designing amaterial
that will ghtmultidrug resistance and encrustation is crucial in UTI
and CAUTI treatment. Themain goal in UTI and CAUTI treatment is
to prevent the adhesion of bacteria and further biolm development.
Therefore, the aim of this research was to nd an adequate
and potential antibacterial agent that will be particularly effective
against P. mirabilis, E. coli and P. aeruginosa. One of the possibil-
ities for UTIs and CAUTIs treatment is the usage of poly-
saccharides and bacterial cellulose composites. Polysaccharides
have diverse biological functions and their low toxicity, biocom-
patibility and high biodegradability are the properties that make
them promising biomaterials.3 Among them are chitin, chitosan,
alginate, cellulose and cellulose based antimicrobial materials
used in research of cosmetics, drug delivery, food packaging, tissue
engineering and wound healing.4–7
Bacterial cellulose (BC) is a natural 3D network polymer


































































































View Article Onlineby Gluconacetobacter xylinus (formerly Acetobacter xylinum). In
comparison with plant cellulose, BC is devoid of hemicellulose
and lignin, has higher degree of polymerization and crystal-
linity (water content up to 99%), insoluble in water and most of
organic solvents, melting point of 467 C, good sorption of
liquids, high wet strength, high chemical purity and as
biocompatible material,8 it is interesting material in developing
of wide range of biomedical applications.9 BC itself does not
have antibacterial activity but combined with organic and
inorganic materials with antibacterial activity could be used as
potential biomedical agent.10
Chitosan (Chi) is linear polysaccharide provided by deace-
tylation of chitin with 40–50% alkaline solution. Depending of
degree of deacetylation and molecular weight chitosan has
different physical properties and different antimicrobial
effect.11 Since it was found that low molecular weight Chi (Chi
oligosaccharides higher than 10 kDa) has better antimicrobial
inhibition in comparison to high molecular weight Chi (more
than 250 kDa),12 in this study was used low molecular weight
Chi (50–190 kDa) to test its effect on bacterial strains the most
present in UTIs and CAUTIs. Lin et al.13 produced BC–Chi
composites by immersing BC in Chi followed by freeze-drying.
These composites showed signicant growth inhibition
against E. coli and S. aureus. Jia et al.14 prepared composites of
Chi chloride and BC by in situ method and showed their
moderate bacteriostatic activity against E. coli. Furthermore, the
inhibition effect of bacteria growth was signicantly enhanced
by increasing the Chi content in the composites. Wahid et al.15
developed BC–Chi based semi-interpenetrating hydrogels with
improved mechanical and antibacterial properties. The authors
found that antibacterial properties of these hydrogels depended
signicantly on the ratio of BC to Chi.
Since hydrogels coatings increases hydrophilicity and
establish a barrier to inhibit nonspecic bacteria protein
adsorption,16 it is proposed that BC as hydrogel and good carrier
of antimicrobial materials17 might be promising agent in UTIs
and CAUTIs. So far, the hydrogel catheter coatings are
combined with inorganic, synthetic materials and antibiotics
which may cause immunogenicity or simple no effect because
of the resistance to antibiotics in the coating.16 The antibacterial
hydrogel catheter coatings with natural materials is promising
strategy in this eld.
In this work, the new designed composite hydrogels of BC
and low molecular weight synthetic polymer Chi (BC–Chi) were
prepared and studied in details on structural, chemical and
biomedical properties. Since the urinary catheter hydrogel
coatings are proposed as successful reducer of encrustation, in
comparison to pure silicon,18 one of the idea was to incorporate
Chi in BC matrix as potential coating for urinary catheters.
Different tests have been conducted to check Chi release from
BC, antioxidant activity of this composite, biocompatibility as
well as its antibacterial potentials against different bacterial
strains. The bacterial morphology aer the application of
control BC and BC–Chi composites was presented by atomic
force microscopy. Since antibacterial tests included strains
which cause UTIs, CAUTIs and encrustation, this composite is8560 | RSC Adv., 2021, 11, 8559–8568proposed to be potential formulation suitable for application as
treatment or prevention of UTIs, CAUTIs and encrustation.
Experimental
Synthesis of bacterial cellulose (BC) and preparing of BC–Chi
composites
The bacterial culture Komagataeibacter intermedius IMBG180
(the collection of microorganisms of the Institute of Molecular
Biology and Genetics, Kyiv, Ukraine) was used for the cellulose-
based lm production. Aer 5 days of incubation at 30 C in HS
medium, the bacterial cellulose (BC) synthesized on the surface
of the medium was harvested and puried with the method
described in details by Kukharenko et al.19
The low molecular weight chitosan (Chi, 50–190 kDa, 75–
85% deacetylated, Aldrich, Germany) dissolved in 1% acetic
acid (ZORKA Pharma-HEMIJA d.o.o., Serbia) mechanically stir-
red at room temperature for 3 h was used in preparation of BC–
Chi composites. The composites named BC–Chi0.2 and BC–
Chi2 were prepared by immersing of BC into 0.2% and 2% Chi
solutions for 48 h, respectively. In order to remove the excess of
solution the samples were lightly dashed on lter paper and
depending of the characterization analysis samples were used
as previously described or dried, on air (50 C for 2 h) or
lyophilized (30 C for 12 h at 10 mTorr, Mini Fast 680 labo-
ratory freeze-dryer, Edwards Ltd, UK).
Atomic force microscopy (AFM) and scanning electron
microscopy (SEM) imaging
Surface morphology measurements of control BC, composite
samples and bacteria aer the application of control BC and
BC–Chi composites were conducted on AFM using Quesant
microscope (Ambios Technology, USA) operating in tapping
mode in air at room temperature, using a silicone T-shaped
cantilever with a spring constant of 40 N m1 and SEM (JEOL
JSM-6390LV) in vacuum at room temperature with accelerating
voltage of 15 kV. For AFM and SEMmeasurements were used air
dried and lyophilized composite samples, respectively.
For AFM images of bacteria aer the application of control
BC and BC–Chi composite samples, it was conducted a pilot try-
out to determine the appropriate way of cell xation (hot air, in
ethanol, glutaraldehyde and Gram stain). The most suitable
method was hot air drying and xation, where the morphology
of cells aer the application of control BC were as typical.
Surface roughness, diameters and height of control BC,
composites BC–Chi0.2 and BC–Chi2 as well as height distribu-
tion, length and width of bacteria were calculated by Gwyddion
soware.
Raman and Fourier transform infrared (FT-IR) spectroscopy
To assess the structural differences between control BC and BC–
Chi0.2 and BC–Chi2 composites, Raman and FTIR spectroscopy
measurements were conducted. Raman spectra of BC and BC–
Chi2 composite samples were recorded on a confocal Raman
microscope (Alpha 300 R+, Witec, Ulm, Germany) in the spectral


































































































View Article OnlinemW power) was focused using the 100 objective onto the
sample surface. All samples were recorded in air at room
temperature. The Raman spectra were acquired in ve different
points. FTIR measurements were performed on a Nicolet 8700
spectrometer operated in the ATR mode. The samples were air
dried and measurements were performed at room temperature
in the range from 400–4000 cm1 whereas spectral resolution
was 4 cm1.
X-ray diffraction (XRD)
The phase composition of lyophilized control BC, BC–Chi0.2
and BC–Chi2 composite samples were examined on Rigaku
Smart Lab diffractometer operating with Cu Ka1,2 radiation at
40 mA and 30 kV. XRD data were collected in the 2q range from
5 to 90, counting 2 per minute in 0.02 steps. Percent crys-
tallinity obtained by X-ray measurements was dened as the
ratio of intensity from the crystalline peaks to the sum of the
crystalline and amorphous intensities, by applying the
equation:
Xc (%) ¼ (Acr/(Acr + Aam))  100 (1)
where Acr and Aam were the integrated areas of the crystalline
and amorphous peaks.
X-photoelectron spectroscopy (XPS)
To check the chemical composition of control BC, BC–Chi0.2
and BC–Chi2 composites all samples were drop-casted on Al
foils and XPS measurements were performed on a Thermo
Scientic K-Alpha XPS system (Thermo Fisher Scientic, UK).
Chi loading in BC–Chi composites
Nine replicates of unloaded BC hydrogel lms were dried with
lter paper, weighted and immersed in 0.2% and 2% Chi
solutions at room temperature for 48 h. Aer 48 h the loaded
hydrogels were weighed and Chi load was determined by using
equation:16
Drug loading (%) ¼ ((mt  m0)/m0)  100 (2)
where m0 was the initial weight of unloaded BC and mt was the
weight of BC–Chi composite.
In order to test the statistical differences between the data of
Chi loading in BC–Chi0.2 and BC–Chi2 it was used Student t-test.
In vitro release of Chi from BC–Chi composite hydrogels
In vitro release of Chi from the BC–Chi2 composite samples was
monitored in 15 mL PBS, pH 7.4, at 37 C with constant shaking
at 100 rpm.20 The composite samples were cut into disks 22 mm
in diameter and 1mm average thickness. Aliquots of the sample
(1 mL) were taken at predetermined time intervals (1, 2, 3, 4, 5,
6, 24, 48 and 72 h) and released Chi in dissolution media was
determined spectrophotometrically (Shimadzu, Kyoto, Japan) at
290 nm. Immediately aer measuring absorbance, aliquots
were poured back in dissolution media, to maintain a constant
volume. All experiments were performed in duplicate.© 2021 The Author(s). Published by the Royal Society of ChemistryAntioxidant activity of BC–Chi composites determined by
DPPHc free radical assay
The DPPH assay was used to predict antioxidant activity. 2,2-
Diphenyl-1-picrylhydrazyl (DPPH) is a stable radical with ability
to react with free radicals changing its colour from purple to
yellow. The control BC and BC–Chi composite sample disks
6 mm in diameter were immersed in 1 mL 100 mM DPPHc
ethanol solution and incubated in dark for 9 days. The
absorption intensity of DPPHc was monitored spectrophoto-
metrically (Shimadzu, Kyoto, Japan) at 518 nm in pre-
determined time intervals (30 min, 1 h, 2 h, 3rd day, 6th day and
9th day). The radical scavenging activity (RSA) of BC–Chi
composites was calculated from the following formula:
RSA (%) ¼ (Ac  ABC–Chi)/Ac  100 (3)
where Ac was the absorbance of DPPHc solution at 518 nm with
BC samples (BC, control), ABC–Chi was the absorbance in the
presence of the composite samples. The maximum absorbance
value (1.000 a.u.) was recorded for DPPHc solution without
samples and was used as blank. Lower absorbance of the
reaction mixture indicates higher free radical scavenging
activity. All measurements were done in triplicates. The data
were presented as values of RSA  standard deviation and
statistically analysed by one-way analysis of variance (ANOVA)
and post hoc Tukey's test. Statistical signicance for all tests was
set at a probability of p < 0.05.Mitochondrial activity (MTT) assay
Human gingival tissues were obtained, and human gingival
cells (HGC) were isolated as described previously by Mancic
et al.21 Briey, tissues from healthy donors that provided written
consent were minced into 1 mm3 fragments and subjected to
outgrowth method. Minced tissue was placed in 25 cm2 culture
asks with growth medium (Gibco Dulbecco's modied Eagle's
F12 medium (DMEM/F12) supplemented with 10% fetal bovine
serum (FBS) and 1% antibiotic/antimycotic (ABAM), all from
Thermo Fisher Scientic), and incubated in humidied 5% CO2
atmosphere at 37 C. The cells were regularly passaged upon
reaching 80–90% conuence. The culture medium was changed
every 3 days. HGCs aer the third passage were used in the
study.
For assessment of mitochondrial activity, BC, BC–Chi0.2 and
BC–Chi2 samples were prepared as described earlier. Prepared
discs were placed in 96-well plates, and DMEM/F12 supple-
mented with 2% ABAM was added to the wells and incubated in
humidied 5% CO2 atmosphere at 37 C for 24 h. Medium was
discarded, 5000 HGC cells per well were seeded onto discs in
freshly prepared growth medium, and incubated. Aer 24 h
medium was discarded, and medium containing 0.5 mg mL1
3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide
(MTT, Sigma-Aldrich, St. Louis, USA) was added to each well,
and incubated for 4 hours, as previous described by Castiglioni
et al.22 Aer incubation, supernatant was discarded, and
dimethyl sulfoxide (Sigma-Aldrich, St. Louis, USA) was added to


































































































View Article Online250 rpm, in dark, at 37 C. Extracted coloured solutions were
transferred into new 96-well plate. Optical density was
measured at 540 nm using microplate reader RT-2100c (Rayto,
China). Six wells without discs were used as internal control of
experiment. Percentage of mitochondrial activity was calculated
as difference to the control group (BC).Fig. 1 Control BC (left) and BC–Chi composite (right).
Antibacterial in vitro test of BC–Chi composites
The antibacterial activity of control BC and BC–Chi composite
samples was examined on following bacterial strain set of
Gram-positive bacteria: Staphylococcus aureus (ATCC 25923),
Enterococcus faecalis (ATCC 29212), Streptococcus agalactiae –
group B Streptococcus b haemolytic (SBH, ATCC 27956) as well as
Gram-negative bacteria: Escherichia coli (ATCC 25922), Klebsiella
pneumoniae (ATCC 700603), Proteus mirabilis (ATCC 29906) and
Pseudomonas aeruginosa (ATCC 27853). The microorganisms
were obtained from Department for Bacteriology and Parasi-
tology, Veterinary Institute of Serbia, Belgrade. Prior experi-
ments, bacterial stocks were cultured on cation adjusted
Mueller Hinton Agar (MHA, Mueller Hinton II agar, Becton,
Dickinson and Company, USA) at 37 C for 24 h. ISO 20776-1
method was used. In brief: overnight bacterial cultures were
suspended in sterile saline for nal cell concentration of 5 105
CFU mL1 (range 2  105 CFU mL1 to 8  105 CFU mL1). The
control BC discs (6 mm in diameter, 1 mm in height and with
average weight 0.018 g) and composite BC–Chi0.2 and BC–Chi2
discs (6 mm in diameter, 1 mm in height and with average
weight of 0.030 g and 0.023 g, respectively) were added to 100 mL
cation adjusted Mueller Hinton Broth (MHB, Mueller Hinton II
agar, Becton, Dickinson and Company, USA) followed by
bacterial inoculum. The minimum inhibitory concentrations
(MICs) were determined using sterile polystyrene, 96-well, U
bottom, microtitre plates (Salsted, Denmark) and minimum
bactericidal concentrations (MBCs) were determined aer MIC
in subsequent sub-cultivation of 10 ml of broth from wells
without growth (i.e. obvious button or denite turbidity) to MHA.
Aerobe incubation for 24 h at 37 Cwas set for all plates. Exceptions
were made for SHB growth media, where MHA supplemented with
5% blood, and MHB with 5% horse serum supplementation were
used. The MIC recorded represents the lowest concentration of the
samples that completely inhibits visible growth, while MBC repre-
sents the lowest concentration of the samples achieving 99.9%
killing of the original inoculums (NCCLS 1999), thus growth of less
than 5 CFU on subsequent plating indicates MBC. Experiment was
performed in quadruplicate.Fig. 2 Top view atomic forcemicroscopy images of: (a) control BC; (b)
BC–Chi0.2 composite and (c) BC–Chi2 composite and scanning
electron microscopy images of: (d) control BC; (e) BC–Chi0.2
composite and (f) BC–Chi2 composite.Results and discussion
Physical and chemical characterization of BC–Chi composite
hydrogels
AFM and SEM imaging. The control BC hydrogels showed
white color appearance while BC–Chi composites were slightly
yellow and sticky (Fig. 1).
Aer the drying process (air dried and lyophilized, AFM and
SEM respectively) samples were used for characterization. In8562 | RSC Adv., 2021, 11, 8559–8568Fig. 2 are shown top view AFM images and SEM micrographs of
control BC and BC–Chi0.2 and BC–Chi2 composites.
The surface morphology of control BC and BC–Chi0.2
showed brous texture, whereas BC–Chi2 had granular struc-
ture. The control BC with smooth texture was consisted of the
interconnected network of fairly uniform in width BC bers
organized into laments around 120 nm in diameter. Lin et al.23
described that cellulose polymer had a network like structure
consisted of glucose chains forming bers are further aggre-
gating in ribbons (3 nm), and these ribbons, aggregating in
laments (30–100 nm). The BC–Chi composites exhibited rough
texture with average surface roughness 26.04 nm and 0.8 nm,
for BC–Chi0.2 and BC–Chi2, respectively. The control BC
showed the highest average roughness of 36.04 nm. The SEM
images showed a Chi concentration-dependent decrease in the
amount of pores in the composite samples. BC–Chi2 is almost


































































































View Article OnlineChemical composition
To determine chemical composition of BC, BC–Chi0.2 and BC–Chi2
composites, detailed investigation was performed by XPS, Raman
and FTIR spectroscopy andXRD. Fig. 3 shows XPS, Raman and FTIRFig. 3 (a) XPS survey spectra of BC (black curve) and BC–Chi2 (red
curve); (b) Raman spectra of BC (black curve) and BC–Chi2 (red curve)
samples. The excitation laser was 785 nm. (c) FTIR spectra of BC (black
curve), Chi powder (blue curve), BC–Chi0.2 (green curve), BC–Chi2
(red curve) samples. All spectra are displaced for clarity. (d) XRD
patterns of Chi powder (blue curve), BC (black curve), BC–Chi0.2
(green curve) and BC–Chi2 (red curve).
© 2021 The Author(s). Published by the Royal Society of Chemistryspectra of all samples as well as their XRD patterns. XPS survey
spectra of BC and BC–Chi2 samples are shown in Fig. 3a. The
content of detected elements in both samples is listed in Table 1.
As can be seen from Fig. 3a, C 1s, O 1s and N 1s peaks are
detected in the survey XPS spectra. Aer Chi incorporation in
the BC the content of carbon increases for 3 Atomic% but the
content of nitrogen increases for 4.4 Atomic%. The higher
nitrogen content aer Chi incorporation in BC indicates that
this macromolecule is predominantly adhered to the surface
brils of BC due to high viscosity.24
The Raman spectra of BC and BC–Chi2 composites are pre-
sented in Fig. 3b. Aer incorporation of Chi in BC the most
representative peaks of BC are reduced (374, 1095, 1119, 1332,
1375 cm1).25 The Chi characteristic peaks are overlapped with
BC peaks (895, 1262, 1346, 1377, 1420 cm1).26 There are small
upshis of these peaks (3–5 cm1) compared to pure Chi. The
Chi characteristic peaks in BC–Chi0.2 sample could not be
identied due to small Chi concentration and overlapping with
characteristic Raman BC peaks.
Fig. 3c presents FTIR spectra of BC, Chi powder and BC–Chi
samples. In the FTIR spectra of BC we detected all peaks char-
acteristic for BC: 3347 cm1 (O–H vibrations), 2897 cm1 (C–H
vibrations), 1652 cm1 stem from water molecules in the
amorphous region, 1427 cm1 (C–H vibrations), 1168 cm1
(vibration from the b-anomeric link) and 1080 cm1 (C–O–C
stretching vibrations).24 As for peaks refers to Chi powder we
detected the following peaks: 3358 cm1 (O–H vibrations), 2928
and 2880 cm1 (C–H stretching vibrations), 1652 cm1 (C]O
vibrations), 1597 cm1 (N–H vibrations), 1383 cm1 (C–H
vibrations), 1159 cm1 and 1082 cm1 (C–O–C vibrations).
In the FTIR spectra of BC–Chi0.2 and BC–Chi2 composites
can be observed the peaks at: 3346 and 3340 cm1 (O–H
vibrations), 2897 and 2892 cm1 (C–H vibrations), 1658 and
1653 cm1 (C]O vibrations), 1563 cm1 (N–H vibrations), 1156
and 1162 cm1, 1055 and 1062 cm1 (C–O–C stretching vibra-
tions).26,27 The characteristic peak for Chi powder sample at
1597 cm1 is down shied for BC–Chi2 sample at 1563 cm1. As
for BC–Chi0.2 sample this peak exists but its intensity is low.28
XRD patterns of control BC, Chi powder, BC–Chi0.2 and BC–
Chi2 composite samples are shown in Fig. 3d. Chi powder
shows three peaks at 10.1, 19.8 and 40.6 (blue curve). The
control BC, BC–Chi0.2 and BC–Chi2 samples were amorphous
or with disordered-crystalline phase but showed peaks at 14.2,
16.7 and 22.5, corresponding to the (1–10), (200) and (110)
Miller indices of microbial cellulose.29 The absence of Chi
characteristic peaks at 10.1 and 19.8 in BC–Chi0.2 composite












O 1s 533.0 36.8 O 1s 532.4 29.4
C 1s 286.8 59.5 C 1s 286–0 62.5
N 1s 400.2 3.7 N 1s 399.4 8.1
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Fig. 4 (a) Release profile of Chi from the BC–Chi composites; (b) Chi


































































































View Article Onlineconverted into amorphous form and that Chi is incorporated in
BCmatrix. As for BC–Chi2 sample (red curve), it can be observed
the absence of peak at 10.1 but peak at 19.8 can be observed as
a shoulder of BC peak (designated with black arrow in Fig. 3d –
red curve). The amorphous structure of composites is essential
and provides more solubility, stability and it is strong associ-
ated with drug release rate (in detail Section In vitro release of
Chi from BC–Chi composites). Since antimicrobial agents
require water for activity, improving the water solubility of Chi
by chemical modication (alkylation, acylation, quaternization,
metallization.) its biomedical application is widened.30 The
Chi crystallinity depends on the degree of deacetylation.31
Namely, Chi chains with higher degree of deacetylation are
more compact thus enables hydrogen bond formation, which is
affected by the content of glucosamine groups. The degree of
crystallinity (Xc, in percentage) for Chi powder, control BC, BC–
Chi0.2 and BC–Chi2 composite samples were 99.0, 62.6, 68.6 and
68.9%, respectively. Thus the Chi incorporation into BC matrix
contributed to slight improvement of BC crystallinity and showed
concentration-dependent trend. The values of full width at half
maximum (FWHM) for Chi powder, control BC, BC–Chi0.2 and
BC–Chi2 composite samples are presented in Table 2.
The broadened characteristic peak of BC at 22.5 for BC–
Chi2 sample (red curve in Fig. 3d) indicates the successful
incorporation of Chi into BC brous matrix.
By conducting different techniques to check chemical
composition of control BC, BC–Chi0.2 and BC–Chi2 composites
we established that Chi was found not only on the composite
surface but also in the interior of BC matrix.
Chi loading in BC–Chi composites
The results of Chi loading in BC–Chi composites show that BC
is loaded more with Chi from 0.2% Chi solution then from 2%
Chi solution. The Chi loading in BC–Chi0.2 was 57.68% and in
BC–Chi2 was 42.08%. However, statistical analysis show no
differences in Chi loading between this two composites.
In vitro release of Chi from BC–Chi composites
In Fig. 4a, the release prole of Chi from BC–Chi2 composites is
shown. In the rst hour of monitoring it is released less than 3%Table 2 The position and full width at half maximum (FWHM) values of
control BC, BC–Chi0.2 and BC–Chi2 composite samples
2q FWHM
Chi powder 10.1 2.89
19.8 4.75
40.6 7.38









8564 | RSC Adv., 2021, 11, 8559–8568of Chi. During the rst 24 h, the total released is 8.8% and in the
next two days it is slowly released 5% more. At the end of
monitoring time (72 h) it is released 13.3% of Chi. In order to
characterize the mechanism of Chi release, the experiment data
were tted into different mathematical models: zero-order, rst-
order, second order, Higuchi model and Korsmeyer–Peppas
kinetic model. The correlation coefficient (R2) was in range of
0.6536–0.9971 for mentioned formulations and the highest
value (R2 ¼ 0.997) was obtained for the Korsmeyer–Peppas
model, the mathematical model for release behaviour of drug
from hydrophilic polymeric matrix, with equation: Mt/MN ¼
Kmt
n, whereMt is an amount of drug released at time t in hours,
MN is a total amount of drug in dosage form, Km is a kinetic
constant and n is the release exponent related to the mecha-
nism of the release. The n value (n¼ 0.374) was smaller than 0.5
(Fig. 4b) indicating that the release of Chi from BC–Chi
composite can be characterized as a quasi-Fickian diffusion.
From all obtained results it is obvious that Chi was
constantly released in small amount during the 72 h and that
release of Chi is partially directed by diffusion from BC
dependent on swellabillity of hydrogels. Insolubility of Chi in
PBS and electrostatic interaction with BCmight be the reason of
very slow Chi releasing. Cabañas-Romero et al.32 showed also
very small amount of Chi release (5%) from BC–Chi composites
aer 96 h incubation in aqueous medium. The release of Chi
depends of its molecular weight and the pH of solution.33 The
authors showed that low molecular weight Chi leakages more
from composites and in solution with pH < 7.4 the releasing


































































































View Article Onlinecorrespondence to the solubility of Chi in acidic medium. Since,
pH of urine in UTIs and CAUTIs is in range of 8.5 to 9, BC–Chi
composites with slow Chi release makes it suitable for main-
taining antimicrobial capacity. In further studies, it will be
monitored for how long Chi can diffuse from hydrogel.Fig. 6 Mitochondrial activity 24 h after direct cell seeding on BC, BC–
Chi0.2, and BC–Chi2 samples. One-way ANOVA revealed no statistical
differences between groups, p < 0.05.Antioxidant property of BC–Chi composites – DPPH
scavenging assay
DPPHc (2,2-diphenyl-1-picryl-hydrazyl-hydrate) is free radical
stable at room temperature which in antioxidant assay produces
a violet solution in ethanol. It is used in easy and rapid anti-
oxidant assay where in presence of an antioxidant molecule the
ethanol solution become colourless and evaluation of antioxi-
dant activity is evaluated spectrophotometrically at 518 nm.
From these results it is clear that even control sample, BC
itself shows low antioxidant activity, but in comparison to
composite samples it is obvious that Chi shows signicant role
in DPPHc scavenging activity (Fig. 5). Concentration dependent
antioxidant activity of BC–Chi0.2 and BC–Chi2 composites
show peaks at 3rd and 6th day with RSA values 17% and 36%,
respectively. Since the composite samples were immersed in
DPPHc solution during the whole experiment and monitoring
time of 9 days, the hydrogels swelled and depending of the Chi
incorporated and/or covering the BC in composites this ability
was more or less rapid. In the case of BC–Chi0.2 where the BC
laments were not totally covered by Chi (in correspondence
with Fig. 2b and e), the swelling of hydrogel was faster and the
maximum antioxidant activity was detected on 3rd day. The
composite BC–Chi2, totally covered with Chi (in correspon-
dence with Fig. 2c and f), swelled slower and the maximum
radical scavenging activity was observed on 6th day. In many
studies is already conrmed antioxidant effect of Chi,34 but for
BC it was only cited in study Schönfelder et al.35 and described
as little antioxidant capacity against ROS. Recently, Yin et al.36
reported weak antioxidant activity of the BC–Chi composites.
But, Cabañas-Romero et al.32 claim that BC–Chi paper has veryFig. 5 Antioxidant activity of BC–Chi composites – DPPH scavenging
assay. Radical scavenging activity (RSA; in percent) of composites (BC–
Chi0.2 and BC–Chi2) and control (BC) samples. One-way ANOVA
revealed statistical differences between groups, *p < 0.05, **p < 0.01,
***p < 0.001. The difference between control and BC–Chi composites
are presented with red asterisks and the differences between BC–Chi
composites with black asterisks.
© 2021 The Author(s). Published by the Royal Society of Chemistrygood antioxidant property due to mainly amino groups residue
from Chi and secondarily to OH groups of Chi that have the
capacity to scavenge radicals. Since UTIs cause oxidative stress,
increase lipid peroxidation level, and lead to insufficiency of
antioxidant enzymes37 the BC–Chi composites may be consider
as biomedical agent in UTIs treatment.
Cytotoxicity test
The BC–Chi0.2 and BC–Chi2 composites do not signicantly
affect mitochondrial activity of cells seeded directly onto
materials in comparison to control disks (BC), as shown in
Fig. 6. Aer 24 h of cells direct exposure to the investigated
materials, mean mitochondrial activity was over 85% for both
concentrations of the tested material. The biocompatibility
results are in correlation with already published literature with
BC–Chi composites.13,14
Antibacterial in vitro tests
The antibacterial activity, presence of inhibition and bacteri-
cidal effect, of control BC, BC–Chi0.2 and BC–Chi2 composite
samples are shown in Table 3. The both groups of BC–ChiTable 3 Antibacterial activity of control BC, BC–Chi0.2 and BC–Chi2
samples on bacteria reference strains S. aureus, E. coli, K. pneumoniae,








MIC/MBCb MIC/MBC MIC/MBC MIC/MBC
S. aureus +/+a +/+ / 0.156/0.156
E. coli +/+ +/+ / 0.313/0.625
K. pneumoniae +/+ +/+ / 5/5
P. mirabilis +/+ +/+ / 0.625/0.625
P. aeruginosa +/+ +/+ / 0.625/0.625
E. faecalis +/+ +/+ / 5/10
Str. b hemo +/+ +/+ / 2.5/5
a “+” the effect was observed; “” the effect was not observed. b MIC –
minimum inhibitory concentration; MBC – minimum bactericidal
concentration.


































































































View Article Onlinecomposite samples exhibited both the inhibition and bacteri-
cidal activity on all tested Gram-positive and Gram-negative
strains. The smaller dose of Chi in composites showed both
inhibition and bactericidal effect on P. mirabilis, P. aeruginosa,
E. faecalis and Str. beta hemo. In the study Kingkaew et al.,33 it
was showed that BC–Chi lms had no inhibitory effect on the
growth of E. coli. The differences in response to Chi between
Gram-negative and Gram-positive bacteria are showed in many
studies. Wang et al.38 designed chitosan–Zn complex and
showed no signicant differences of the effect against Gram-
negative and Gram-positive bacteria but there were many
studies where was stronger antibacterial activity against Gram-
negative bacteria than against Gram-positive bacteria.39 Gram-
negative bacteria have more negative charge on the cell
surface than Gram-positive bacteria and a lot of positively
charged amine groups of Chi strongly interact with carboxyl-
negative charges, change the membrane permeability, leads to
its destabilization, mostly followed with leakage of intracellular
substances and the cells death which is in correspondence with
higher inhibitory effect of Chi against Gram-negative bacteria.40
The binding of Chi also promptly neutralizes and even reverses
the surface charge of the bacteria,41 but also the chitosan-
mediated chelation of metal ions combined with cell wall
molecules crucial for cell wall stability are oen been implicated
as a possible mode of antimicrobial action.42
In other studies, it was also reported good antibacterial
potentials against S. aureus and E. coli36 and against P. aerugi-
nosa and yeast Candida albicans.33
Fig. 7 presents AFM images of P. mirabilis and P. aeruginosa
morphology treated with BC (control) samples and BC–Chi2
composite samples. It can be seen that both strains aer the
application of BC–Chi2 composites were with rough surface and
agglomerated. The height distribution of P. mirabilis control
and BC–Chi2 treated was almost similar, 0.18 mm and 0.22 mm,
respectively. In the case of P. aeruginosa aer the BC–Chi2
treatment the height distribution was decreased to 0.04 mm (forFig. 7 Top view AFM images of P. mirabilis and P. aeruginosa before (a
and c) and after (b and d) the application of BC–Chi2 composite.
8566 | RSC Adv., 2021, 11, 8559–8568control samples the height distribution was 0.36 mm). This
conrmed that aer the treatment with BC–Chi2 composites P.
aeruginosa was attened. Also, both bacterial strains were
shrunk aer the application of composites. The length and
width of P. mirabilis was decreased aer the BC–Chi2 composite
application (control length and width 1.92 mm and 1.15 mm;
aer the BC–Chi2 application length and width 0.78 mm and
0.38 mm). The length of P. aeruginosa treated with BC–Chi2
composite was also decreased to 1.14 mm (control 1.65 mm),
while the width was almost similar 0.79 mm (control 0.75 mm).
From all the obtained results, this new BC–Chi composites
might be considered as coating for urinary catheters for
prevention of encrustation in CAUTIs, since it was showed
bactericidal effect on strain P. mirabilis, the strain responsible
for encrustation. In the review43 authors cited the potential
coatings for urinary catheters and discussed their effectiveness
in preventing biolm forming.
The mechanism how BC–Chi composite acts against these
bacteria might be by binding to the negatively charged bacterial
cell wall disrupting cell membrane and resulting in leakage of
intracellular components and cell death, which is in correlation
with already published results.44
Conclusions
In this study, the composites of bacterial cellulose and low
molecular weight synthetic polymer chitosan (BC–Chi) were
prepared and characterized in detail. XPS, Raman, FTIR and XRD
measurements of new designed composites show successful chi-
tosan polymer incorporation in bacterial cellulose matrix.
The composites show strong antibacterial activity against
strains the most found in patients with bacterial urinary tract
infections, where bactericidal effect is achieved on all other
tested strains. The most challenging results are bactericidal
effect on P. mirabilis, the strain responsible for encrustation in
catheter associated urinary tract infections, as well as on the most
frequent strains in urinary tract infections E. coli and P. aeruginosa.
The AFM images of bacterialmorphology aer the application of BC–
Chi composites show their alternation, where they are shrunk, at-
tened and agglomerated. The putative mechanisms of the Chi anti-
bacterial activity are hidden in the interaction of the BC–Chi
composites with the bacterial outer membrane, as well as they are
associated with a number of factors that act in an orderly indepen-
dent fashion. These BC–Chi composites show very good RSA activity
with the peak at 36% aer the 6th day of observation. In in vitro
conditions, chitosan is constantly released in small amount during
the 72 h and that release is partially directed by diffusion from BC-
dependent swellabillity of hydrogels. Obtained results indicate high
potential of these composites for successful elimination of bacteria
and their promising usage in UTIs andCAUTIs treatments, as well as
urinary catheter coating in prevention of encrustation.
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Todorović Marković also thanks for funding by a STSM grant
from the COST Action CA16217 “ENIUS” and funded by COST
(European Cooperation in Science and Technology). Authors
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